Metraipolis › archive › dc_7fad6d699461

Comparative Efficacy and Cycle-Wise Toxicity of Paclitaxel-Carboplatin Versus Gemcitabine-Cisplatin in Stage IV Non-small Cell Lung Cancer (NSCLC): A… — Europe PMC PMID:41141108

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41141108
DOI
10.7759/cureus.93093
License (as archived)
solo-consultazione
Archived
2026-11-09T19:12:50.791Z
SHA-256 of the archived text
794226e5863ec499a9002892f06c6b74319d9fb65332b9ce78b02b110248f209
Stable URL of this page
https://metraipolis.com/documento/dc_7fad6d699461

How to cite

Comparative Efficacy and Cycle-Wise Toxicity of Paclitaxel-Carboplatin Versus Gemcitabine-Cisplatin in Stage IV Non-small Cell Lung Cancer (NSCLC): A… — Europe PMC PMID:41141108 — Europe PMC (en), https://europepmc.org/article/MED/41141108 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fad6d699461 (Metraipolis archive dc_7fad6d699461, sha256 794226e5863ec499a9002892f06c6b74319d9fb65332b9ce78b02b110248f209)
BibTeX
@misc{dc7fad6d699461,
  title = {Comparative Efficacy and Cycle-Wise Toxicity of Paclitaxel-Carboplatin Versus Gemcitabine-Cisplatin in Stage IV Non-small Cell Lung Cancer (NSCLC): A… — Europe PMC PMID:41141108},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41141108},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fad6d699461; sha256 794226e5863ec499a9002892f06c6b74319d9fb65332b9ce78b02b110248f209},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41141108. Agents can read the archived copy with the MCP tool read_document.